Home / Letter From The Editor (page 125)

Letter From The Editor

Letter from the Editor #480

This is an exciting week for many of our readers. As you receive this newsletter over 3,000 of the most recognized experts in Diabetes Care, CDE’s, will be gathering in Atlanta for the American Association of Diabetes Educator’s 36th Annual Meeting. This year there is a lot to talk about. …

Read More »

Letter From The Editor. July 15, 2009 Issue #477

The controversy about Lantus and cancer continues to heat up. Leading experts are coming forward to share their opinions on the meta-analysis. It is too bad that the lay press will never get these expert opinions to our patients. Last week Diabetes Technology & Therapeutics published an outstanding editorial by three …

Read More »

Letter From The Editor. June 29, 2009 Issue #475

EXTRA – SPECIAL JULY 6th EDITION:  Top Clinicians Share Lantus Guidance  Click here for the inside stories…   Lantus Cancer Concern Inconclusive Details of a new study, “Lantus insulin: a possible link with cancer which requires further investigation,”to be published in the Journal of the EASD, “Diabetologia,” have been leaked. This …

Read More »

June 3, 2009, Issue #471

A couple of weeks ago we had a new product blurb about Cycloset™, an old drug with a new indication for diabetes. Many of you wrote to ask me for information on how the medication works and where the idea came from. I had our current PharmD candidate, Robert Fredenrich, …

Read More »

June 16, 2009 Issue #473

Last year at the ADA 68th ADA Scientific Sessions, results from the ACCORD and VADT studies indicated that tight glucose control increased the risk of cardiovascular death. This year they reviewed the results again and found that the headlines were unfounded. Now they have reversed their opinions and are saying …

Read More »

June 10, 2009, Issue #472

We are back from the 69th ADA Scientific Sessions and there were a lot of new studies, practice pearls and products in development. We have stocked this weeks issue with some of the early highlights and will have more over the next few weeks as our editorial staff has time …

Read More »